Mineralocorticoid receptors (MR) are found not only in classical aldosterone target tissues (kidney, colon, parotid) but also non-pithelial tissues such as hippocampus. In addition, MR have equivalent affinity for cortisol (in the rat corticosterone) as for aldosterone, which circulates at very much lower levels. Aldosterone occupancy of MR in physiologic target tissues but not hippocampus reflects the activity in these tissues of the enzyme l l~h y d r o x y s t e r o i d dehydrogenase (llHSD), which converts cortisol and corticosterone to receptor-inactive 11-keto congeners; aldosterone escapes equivalent metabolism as its C11-OH is stably cyclized with the very reactive aldehyde group a t (218. Studies currently in progress in this area include (1) characterization of the NAD4ependent llHSD species (11HSD2) operant in renal distal tubule distinct from the cloned enzyme (11 HSD1) expressed in proxlmal tubule, testis, liver and lung; (2) exploration of the physiologic roles of 'MR' in hippocampus, where they are occupied by cortisol/corticosterone, and function as high-affinity glucocorticoid receptors; (3) recognition of the basis for MR and GR specificity at the transcriptional level, by oncogene product binding and/or response element differences; (4) investigation of the evolutionary basis for nonselective MR by comparative studies on guinea pigs and hamsters, and (5) X chromosome inactivation is a developmentaily regulated process, presenr in all mammals, which has presumably evolved t o achieve dosage compensation between males and females in somatic cells. This phenomenon has been under study for more than thirty years in efforts t o gain a better understanding of the control of gene expression, the pathogenesis of various X-linked diseases and sex chromosome aneuploidies, and t o ass ess cell lineage and clonallty in studies o f tumor origins. X chromosome inactivation requires a mechanism for assessing the X/autosome ratio, a process for initiating the cis inactivation of genes on a single X, and a means of stably maintaining a pattern of inactivation once established.
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Over the past few years, it has become apparent that not all genes on the X chromosome are subject t o inactivation. We have been trying t o identify as many such genes as possible as they may provide insight into the mechanisms which produce abnormal phenotypes in the sex chromosome aneuploldies. We have characterized several of these genes, studied the signals which control their expression and investigated their l o c a t~o n and biology o n the mouse X chromosome. A gene studied by several investigators, XIST, has been of particular interest as it is expressed only from an otherwise inactive X chromosome. We have found that XIST is also expressed from the single X chromosome in the testis during meiosls supporting the old theory that X inactivation is required for functional spermatogenesis.
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Methods for introducing genes into mice (transgenic technology) and inactivating genes in mice (gene "knock out" technology) are rapidly contributing to our understanding of the role which specific DNA sequences play in the physiology of the whole organism. Transgenic mice are derived from fertilized zygotes in which micro injected foreign DNA has integrated into the genome. The introduced genetic sequences are present in all cells of the transgenic animal, and the offspring of a transgenic parent inherit the injected DNA sequences in a Mendelian manner. This genetic engineering approach has enabled researchers to create lines of mice which express genes not normally present, and to examine the effects of this expression at an organismal level. Several examples of how transgenic mice have been used to study endocrine disorders will be described. Gene "knock out" mice are animals which have been engineered so that genes normally expressed by the organism have been inactivated. The creation of such animals is dependent upon the use of embryonic stem cells. These cells are primitive germ cells which can be grown in culture but which still maintain the capacity when introduced into a blastocyst to contribute to all cell types of the resulting animal. To make a gene "knock out" mouse, embryonic stem cells growing in culture are transfected with a cloned mouse gene designed to contain a mutation precluding its expression. The transfected gene integrates through homologous recombination, replacing the normal mouse gene in the genome of the stem cells. These cells are then introduced into mouse blastocysts, and the resulting animals are bred to derive a line of mice homozygous for the inactivated allele. Such gene "knock out" mice have been used to study the role of a variety of genes in the whole organism since they lack production of specified gene products. Several examples of how these animals have been used to study endocrine disorders will be described.
